Clinical Trial Update: A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial of allogeneic human dermal fibroblasts for remodeling scar contractures was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Scar
• Hypertrophic Scar
• Scar Contracture

Drugs mentioned

• Allogeneic human dermal fibroblasts (allogeneic human dermal fibroblasts)

Snippet

Sponsor: University of Pittsburgh | Conditions: Restrictive Scar Contracture, Restrictive Hypertrophic Scar | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-05-12